PRA Health Sciences, Inc. logo
PRA Health Sciences, Inc. PRAH

PRA Health Sciences, Inc. Income Statement 2011-2026 | PRAH

Annual Income Statement PRA Health Sciences, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

7.87 B 6.53 B 6.72 B 5.73 B 3.44 B 2.58 B 1.12 B - - -

Shares

63.8 M 64.5 M 64.1 M 62.4 M 60.8 M 60 M 42.9 M - - -

Net Income

197 M 243 M 154 M 86.9 M 68.2 M 81.8 M -35.7 M - -2.71 M -

Revenue

3.18 B 3.07 B 2.87 B 2.26 B 1.81 B 1.61 B 1.46 B - 700 M -

EBITDA

416 M 482 M 429 M 343 M 277 M 243 M 153 M - 77.9 M -

Operating Expenses

585 M 510 M 484 M 400 M 339 M 324 M 351 M - 191 M -

General and Administrative Expenses

453 M 395 M 372 M 322 M 270 M 246 M - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company PRA Health Sciences, Inc. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 16.19 0.5 % $ 174 M chinaChina
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Agilent Technologies Agilent Technologies
A
$ 117.7 2.28 % $ 35.8 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 16.76 4.42 % $ 893 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Interpace Biosciences Interpace Biosciences
IDXG
$ 2.2 -4.35 % $ 9.73 M usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Co-Diagnostics Co-Diagnostics
CODX
$ 1.43 4.38 % $ 1.9 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
- - $ 19.8 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 23.18 0.22 % $ 644 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
Charles River Laboratories International Charles River Laboratories International
CRL
$ 177.87 1.25 % $ 8.82 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
$ 498.89 1.09 % $ 14.4 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 194.47 2.58 % $ 139 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 4.59 5.4 % $ 425 M usaUSA
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
NeoGenomics NeoGenomics
NEO
$ 7.95 3.38 % $ 1.02 B usaUSA
Illumina Illumina
ILMN
$ 126.18 4.34 % $ 20.1 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 15.34 6.31 % $ 464 M usaUSA
Guardant Health Guardant Health
GH
$ 80.98 3.03 % $ 10.2 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Senseonics Holdings Senseonics Holdings
SENS
$ 6.69 0.15 % $ 279 M usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 2.77 2.79 % $ 89.9 K usaUSA
Biomerica Biomerica
BMRA
$ 2.07 -3.05 % $ 4.75 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
- - $ 21.2 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 28.52 0.76 % $ 20 B niderlandNiderland
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 110.04 3.02 % $ 9.08 B irlandaIrlanda
Soleno Therapeutics Soleno Therapeutics
SLNO
$ 52.64 0.01 % $ 2.68 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 263.77 1.09 % $ 21.9 B usaUSA
Natera Natera
NTRA
$ 199.3 3.25 % $ 19.6 B usaUSA
Celcuity Celcuity
CELC
$ 119.06 1.64 % $ 5.57 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 80.85 0.32 % $ 5.46 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
Neuronetics Neuronetics
STIM
$ 1.37 1.11 % $ 90.4 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 190.84 -0.36 % $ 21.2 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 9.32 -1.01 % $ 2.02 B usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
$ 4.97 0.61 % $ 3.91 M usaUSA
Organovo Holdings Organovo Holdings
ONVO
- -2.3 % $ 19.4 M usaUSA